StemRIM (4599.T)
JPY 338.0
(-0.29%)
JPY 338.0
(-0.29%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.07 Billion JPY | -1557.96% |
| 2023 | 142.39 Million JPY | 107.19% |
| 2022 | -1.98 Billion JPY | -233.6% |
| 2021 | -593.72 Million JPY | -242.82% |
| 2020 | 415.71 Million JPY | 157.19% |
| 2019 | -726.86 Million JPY | -93.76% |
| 2018 | -375.14 Million JPY | -133.35% |
| 2017 | -160.76 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -518.42 Million JPY | 4.38% |
| 2024 Q4 | -524 Million JPY | -1.07% |
| 2024 Q2 | -542.19 Million JPY | -10.31% |
| 2024 Q1 | -491.51 Million JPY | 19.81% |
| 2023 Q2 | -529.34 Million JPY | -3.23% |
| 2023 FY | 142.39 Million JPY | 107.19% |
| 2023 Q1 | -512.75 Million JPY | -8.09% |
| 2023 Q4 | -612.95 Million JPY | -134.1% |
| 2023 Q3 | 1.79 Billion JPY | 439.56% |
| 2022 Q2 | -516.71 Million JPY | -5.48% |
| 2022 FY | -1.98 Billion JPY | -233.6% |
| 2022 Q4 | -474.36 Million JPY | 5.08% |
| 2022 Q3 | -499.74 Million JPY | 3.28% |
| 2022 Q1 | -489.86 Million JPY | -169.93% |
| 2021 FY | -593.72 Million JPY | -242.82% |
| 2021 Q4 | 700.48 Million JPY | 235.5% |
| 2021 Q3 | -516.97 Million JPY | -1.61% |
| 2021 Q2 | -508.8 Million JPY | -89.54% |
| 2021 Q1 | -268.43 Million JPY | -133.25% |
| 2020 FY | 415.71 Million JPY | 157.19% |
| 2020 Q4 | 807.3 Million JPY | 996.39% |
| 2020 Q3 | 73.63 Million JPY | 129.65% |
| 2020 Q2 | -248.3 Million JPY | -14.47% |
| 2020 Q1 | -216.92 Million JPY | 1.66% |
| 2019 FY | -726.86 Million JPY | -93.76% |
| 2019 Q4 | -220.58 Million JPY | 0.0% |
| 2018 FY | -375.14 Million JPY | -133.35% |
| 2017 FY | -160.76 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 447.842% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -317.817% |
| GNI Group Ltd. | 13.1 Billion JPY | 115.837% |
| Linical Co., Ltd. | 725.72 Million JPY | 386.059% |
| Trans Genic Inc. | 89.43 Million JPY | 2421.213% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | -45.587% |
| Soiken Holdings Inc. | -610 Million JPY | -240.324% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -168.654% |
| AnGes, Inc. | -11.96 Billion JPY | 82.653% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -85.225% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 78.207% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 2090.431% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -140.162% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -85.859% |
| CanBas Co., Ltd. | -1.26 Billion JPY | -64.501% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -159.969% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -515.357% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | -72.258% |
| Kidswell Bio Corporation | -1.33 Billion JPY | -55.436% |
| PeptiDream Inc. | 6.77 Billion JPY | 130.651% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | -7.566% |
| Ribomic Inc. | -1.11 Billion JPY | -85.989% |
| SanBio Company Limited | -4.53 Billion JPY | 54.263% |
| Healios K.K. | -3.37 Billion JPY | 38.562% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -79.728% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | -48.976% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | -47.969% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 269.955% |
| FunPep Company Limited | -994 Million JPY | -108.853% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -133.583% |
| Stella Pharma Corporation | -760.3 Million JPY | -173.05% |
| TMS Co., Ltd. | -943.25 Million JPY | -120.089% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -167.736% |
| Cuorips Inc. | -588.48 Million JPY | -252.769% |
| K Pharma,Inc. | 366.05 Million JPY | 667.125% |
| Takara Bio Inc. | 3 Billion JPY | 169.131% |
| ReproCELL Incorporated | -409.29 Million JPY | -407.216% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 18865.254% |
| StemCell Institute Inc. | 413.75 Million JPY | 601.741% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 1536.609% |
| CellSeed Inc. | -697.77 Million JPY | -197.517% |